134 related articles for article (PubMed ID: 26261536)
1. Aberrant LRP16 protein expression in primary neuroendocrine lung tumors.
Shao Y; Li X; Lu Y; Liu L; Zhao P
Int J Clin Exp Pathol; 2015; 8(6):6560-5. PubMed ID: 26261536
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
3. Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma.
Meyronet D; Massoma P; Thivolet F; Chalabreysse L; Rogemond V; Schlama A; Honnorat J; Thomasset N
Am J Surg Pathol; 2008 Nov; 32(11):1699-708. PubMed ID: 18769332
[TBL] [Abstract][Full Text] [Related]
4. Stress protein Hsp27 expression predicts the outcome in operated small cell lung carcinoma and large cell neuroendocrine carcinoma patients.
Marinova DM; Slavova YG; Trifonova N; Kostadinov D; Maksimov V; Petrov D
J BUON; 2013; 18(4):915-20. PubMed ID: 24344017
[TBL] [Abstract][Full Text] [Related]
5. The value of immunohistochemical identification of neuroendocrine differentiation in non small cell lung carcinoma.
Słodkowska J
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():23-7. PubMed ID: 9337520
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L
Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856
[TBL] [Abstract][Full Text] [Related]
7. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmall-cell or small-cell type?
Yang YJ; Steele CT; Ou XL; Snyder KP; Kohman LJ
Diagn Cytopathol; 2001 Nov; 25(5):292-300. PubMed ID: 11747218
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of nestin and its association with survival in neuroendocrine lung tumours.
Brominska B; Gabryel P; Jarmołowska-Jurczyszyn D; Janicka-Jedyńska M; Trojanowski M; Sawicka-Gutaj N; Czepczyński R; Gut P; Bromiński G; Dyszkiewicz W; Woźniak A; Ruchała M
Pol J Pathol; 2017; 68(4):291-296. PubMed ID: 29517198
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
Ab' Saber AM; Massoni Neto LM; Bianchi CP; Ctenas BB; Parra ER; Eher EM; Pereira JC; Takagaki T; Yamaguchi NH; Capelozzi VL
Ann Thorac Surg; 2004 Jun; 77(6):1883-90. PubMed ID: 15172229
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
15. Grading the neuroendocrine tumors of the lung: an evidence-based proposal.
Rindi G; Klersy C; Inzani F; Fellegara G; Ampollini L; Ardizzoni A; Campanini N; Carbognani P; De Pas TM; Galetta D; Granone PL; Righi L; Rusca M; Spaggiari L; Tiseo M; Viale G; Volante M; Papotti M; Pelosi G
Endocr Relat Cancer; 2014 Feb; 21(1):1-16. PubMed ID: 24344249
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.
Pocrnich CE; Ramalingam P; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):577-86. PubMed ID: 26945341
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung.
Okada D; Kawamoto M; Koizumi K; Tanaka S; Fukuda Y
Jpn J Thorac Cardiovasc Surg; 2003 Jul; 51(7):272-6. PubMed ID: 12892456
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of LRP16 protein in 336 gastric carcinoma patients.
Li YZ; Zhao P; Han WD
World J Gastroenterol; 2009 Oct; 15(38):4833-7. PubMed ID: 19824120
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance and prognostic value of leukemia-related protein 16 expression in invasive ductal breast carcinoma.
Zhao P; Lu Y; Han W
Cancer Sci; 2010 Oct; 101(10):2262-8. PubMed ID: 20649898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
